Table 3.
Outcome | Study | Intervention |
Direction | Large effect | Statistically significant change | RCT design | Notes on outcome measures | |
---|---|---|---|---|---|---|---|---|
Single-mechanism interventions | ||||||||
Test numbers or rates | Adlan et al22 | Guidelines | + | + | + | − | Per cent admissions offered TFTs | |
Berwick and Coltin17 | Education (test specific) | + | − | NR | − | Per 100 encounters | ||
Berwick and Coltin17 | Feedback on cost | + | − | NR | − | Per 100 encounters | ||
Berwick and Coltin17 | Feedback on yield | − | + | NR | − | Per 100 encounters | ||
Chu et al24 | Guidelines | + | + | + | − | Per 100 ED visits | ||
Cipullo and Mostoufizadeh19 | Guidelines | + | − | NR | − | Per discharge | ||
Gama et al18 | Feedback | + | + | + | − | Per outpatient visit | ||
Emerson and Emerson27 | Request form redesign | + | − | + | − | |||
Feldkamp and Carey28 | Guidelines | + | − | NR | − | Per 1000 patients | ||
Grivell et al29 | Feedback | − | + | NR | − | |||
Horn et al45 | Display of cost of tests being ordered | + | − | − | − | Per 1000 visits | ||
Schectman et al33 | Educational memorandum | + | − | + | − | Per patient | ||
Thomas et al10 | Feedback | + | − | + | + | Per 10 000 registered patients | ||
Thomas et al10 | Reminders | + | − | + | + | Per 10 000 registered patients | ||
Appropriateness (compliance) | Daucourt et al25 | Pocket memory card | + | − | − | + | Proportion of TFTs ordered in accordance with the guidelines | |
Daucourt et al25 | Request form redesign | + | + | + | + | Proportion of TFTs ordered in accordance with the guidelines | ||
Schectman et al33 | Educational memorandum | + | + | + | − | Compliance with TSH-only strategy | ||
Schectman et al33 | Reminders | + | − | + | − | Compliance with TSH-only strategy | ||
Expenditure | Tierney et al35 | Display of computer- generated probability estimates |
+ | − | − | + | Per visit | |
CV | Berwick and Coltin17 | Education (test specific) | − | − | NR | − | ||
Berwick and Coltin17 | Feedback on cost | + | + | NR | − | |||
Berwick and Coltin17 | Feedback on yield | + | + | NR | − | |||
Pattern | Emerson and Emerson27 | Request form redesign | + | + | NR | − | Sought to shift to TSH and thyroid cascade | |
Feldkamp and Carey | Guidelines | + | + | NR | − | Sought to shift to TSH and TSH-based algorithm | ||
Larsson et al28 and Mindemark and Larsson31 | Years 1–2 | Education | + | − | + | − | Sought to shift to TSH; and reduce ordering of TT3 and FT4 relative to TSH. Summary based on TSH/all TFTs ratios | |
Larsson et al28 and Mindemark and Larsson31 | Years 2–6 | Education | − | − | + | − | Sought to shift to TSH; and reduce ordering of TT3 and FT4 relative to TSH. Summary based on TSH/all TFTs ratios | |
Multiple-mechanism interventions | ||||||||
Test numbers or rates | Baker et al | Education and guidelines | + | − | − | + | Per 1000 registered patients | |
Daucourt et al | Pocket memory card and request form redesign | + | − | + | + | Proportion of TFTs ordered in accordance with the guidelines | ||
Dowling et al26 | Education and feedback | + | − | + | − | Per patient visit | ||
Hardwick et al44 | Funding policy and guidelines | + | − | NR | − | |||
Rhyne and Gehlbach43 | Education and guidelines | + | + | + | − | Per 100 encounters | ||
Schectman et al | Feedback and reminders | + | − | + | − | Per patient | ||
Thomas et al10 | Feedback and reminders | + | − | + | + | Per 10 000 registered patients | ||
Tomlin et al36 | Education and feedback and guidelines | + | + | + | − | Per year per GP | ||
Toubert et al37 | Guidelines and reminders | + | + | NR | − | |||
van Walraven et al39 | Guidelines and funding policy | + | + | + | − | Summary based on decrease in the proportion of TT4 and T3RU | ||
van Walraven et al39 | Guidelines and request form redesign | + | − | + | − | Summary based on decrease in TSH utilisation | ||
Vidal-Trécan et al40 | Education and guidelines and request form redesign | + | − | NR | − | Summary based on the total number of TFTs | ||
Willis and Datta41 | Education and guidelines | + | + | + | − | Per admission | ||
Wong et al42 | Guidelines and request form redesign | + | + | NR | − | |||
Appropriateness (compliance) | Dowling et al26 | Education and feedback | + | + | + | − | Per cent TSH indicated | |
Nightingale et al32 | Education and feedback and protocol management system | + | + | NR | − | Per cent patients requiring a particular investigation according to protocol who were actually tested | ||
Rhyne and Gehlbach43 | Education and guidelines | + | − | − | − | Per cent ‘high’ and ‘low’ indications | ||
Schectman et al33 | Feedback and reminders | + | − | − | − | |||
Toubert et al37 | Guidelines and reminders | + | + | + | − | Per cent appropriate | ||
Expenditure | Hardwick et al44 | Funding policy and guidelines | + | + | NR | − | ||
Stuart et al34 | Education and feedback and guidelines | + | + | + | − | |||
Tomlin et al36 | Education and feedback and guidelines | + | − | NR | − | |||
Pattern | Hardwick et al44 | Funding policy and guidelines | + | − | NR | − | Sought to decrease proportion of TT3 as TFTs requested. Summary based on per cent of TFTs TT3 | |
Tomlin et al36 | Education and feedback and guidelines | + | + | + | − | Sought to shift to TSH. Summary based on per cent TFTs TSH alone | ||
Toubert et al37 | Guidelines and reminders | + | + | NR | − | Sought to shift to TSH. Summary based on per cent TFTs TSH alone | ||
van Gend et al38 | Feedback and test form redesign | + | + | NR | − | Sought to shift away from TT4. Summary based on FT4:TSH ratio | ||
Vidal-Trecan et al40 | Education and guidelines and request form redesign | + | − | NR | − | Sought to shift to TSH. Summary based on the proportion of FT3 and TSH | ||
Wong et al42 | Guidelines and request form redesign | + | + | NR | − | Sought to decrease ordering of ‘complete’ thyroid panel to more selective use of individual tests |
Direction: ‘+’ indicates result favours behaviour change intervention; ‘−’ opposite. Large effect: ‘+’ indicates risk difference is ≥20%; ‘−’ <20%. Statistically significant change: ‘+’ indicates 95% CI do not include no effect or p<0.05; ‘−’ opposite. RCT design: ‘+’ indicates study design is RCT; ‘−’ not RCT.
CV, coefficient of variation; ED, emergency department; FT3, free tri-iodothyronine; FT4, free thyroxine; GP, general practitioner; NR, indicates item not reported; RCT, randomised controlled trial; T3RU, tri-iodothyronine resin uptake; TFTs, thyroid function tests; TSH, thyroid-stimulating hormone; TT3, total tri-iodothyronine; TT4, total thyroxin.